PEAK6 Investments’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-6,276
Closed -$80.3K 4332
2022
Q4
$71.6K Buy
+6,276
New +$93K ﹤0.01% 3792
2022
Q2
Sell
-3,379
Closed -$125K 6129
2022
Q1
$125K Sell
3,379
-49,880
-94% -$1.94M ﹤0.01% 4169
2021
Q4
$2.42M Buy
53,259
+21,186
+66% +$1.11M 0.01% 1714
2021
Q3
$2.03M Buy
+32,073
New +$2.44M ﹤0.01% 1945
2020
Q4
Sell
-9,562
Closed -$554K 4616
2020
Q3
$363K Buy
+9,562
New +$323K ﹤0.01% 3091
2019
Q2
Sell
-2,540
Closed -$80K 3712
2019
Q1
$80K Sell
2,540
-28,969
-92% -$844K ﹤0.01% 3306
2018
Q4
$792K Buy
31,509
+16,864
+115% +$433K 0.01% 1965
2018
Q3
$423K Buy
+14,645
New +$274K ﹤0.01% 2681

Other funds holding CDNA

PEAK6 Investments's CDNA Position: Q1 2023 in Review

PEAK6 Investments sold out of CareDx (CDNA) in Q1 2023, closing a stake of 6,276 shares — an estimated $80.3K sold.

PEAK6 Investments first reported a position in CDNA in Q3 2018 and held it in 8 quarters. The position peaked at $2.42M in Q4 2021. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

  • PEAK6 Investments reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
  • PEAK6 Investments sold 6,276 CareDx shares in Q1 2023, an estimated $80.3K.
  • PEAK6 Investments first reported a position in CareDx in Q3 2018 and held it in 8 quarters.
  • PEAK6 Investments's CareDx position peaked at $2.42M in Q4 2021.
  • 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on PEAK6 Investments's 13F filing for Q1 2023, filed 12 May 2023.